Ginkgo Bioworks Holdings (DNA) is a pioneering entity in the synthetic biology landscape, utilizing advanced genetic engineering to craft customized bioengineered organisms across various sectors, including pharmaceuticals, agriculture, and industrial biotech. The company's state-of-the-art platform bolsters cellular design for manufacturing, driving efficiency in product development and production processes. With a strategic emphasis on addressing critical global challenges such as climate change and food security, Ginkgo is uniquely positioned to make substantial contributions across multiple industries while promoting sustainable biotechnology solutions. As the demand for bio-based alternatives intensifies, Ginkgo’s innovative approach and commitment to sustainability offer a promising trajectory for significant growth and impact.
Data last updated: June 12, 2026 at 7:45 AM EDT
Get e-mail RSI alerts when Ginkgo Bioworks Holdings enters oversold or overbought territory. Free forever.
Add Alert